Updates on capivasertib, belzutifan, talquetamab, & durvalumab
Jun 18, 2026 - 00:19:32
Radio and PodcastLive Radio & PodcastsScience & Medicine
Axi-Cel and 5-FU Label Changes
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab nets another approval, this time in conjunction with paclit...
About This Episode
Axi-Cel and 5-FU Label Changes is an episode from OncoPharm by OncoPharmPod. We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab ne...
Podcast
This episode belongs to OncoPharm.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 12, 2026, 00:12:34 long, audio available.
Related Episodes
Continue listening to more episodes from OncoPharm.
Asco '26
Jun 11, 2026 - 00:25:38
Pivekimab sunirine
May 28, 2026 - 00:13:49
BCL2 & HER2 Targeting Agent Updates
May 21, 2026 - 00:13:45
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Vepdegestrant
May 7, 2026 - 00:11:35
Targets Trop 2
Apr 30, 2026 - 00:12:41
Promising Pancreatic Cancer Data
Apr 23, 2026 - 00:13:56